KORU Medical Systems (NASDAQ:KRMD) Insider Adam Kalbermatten Buys 12,500 Shares

KORU Medical Systems, Inc. (NASDAQ:KRMD) insider Adam Kalbermatten bought 12,500 shares of the business’s stock in a transaction dated Thursday, June 11th. The shares were purchased at an average cost of $3.94 per share, with a total value of $49,250.00. Following the completion of the acquisition, the insider owned 312,500 shares in the company, valued at approximately $1,231,250. This represents a 4.17% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

KORU Medical Systems Price Performance

NASDAQ:KRMD opened at $3.87 on Tuesday. The firm has a market cap of $177.75 million, a price-to-earnings ratio of -77.40 and a beta of 0.43. The company has a 50 day moving average price of $4.09 and a 200-day moving average price of $4.82. KORU Medical Systems, Inc. has a 1-year low of $2.91 and a 1-year high of $6.61.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on KRMD shares. Wall Street Zen cut shares of KORU Medical Systems from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. B. Riley Financial lifted their price target on shares of KORU Medical Systems from $7.00 to $8.00 and gave the company a “buy” rating in a research note on Friday, March 13th. Canaccord Genuity Group reissued a “buy” rating and issued a $6.00 price target on shares of KORU Medical Systems in a research note on Friday, March 13th. Finally, Weiss Ratings cut shares of KORU Medical Systems from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, May 29th. Four analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $7.25.

Institutional Investors Weigh In On KORU Medical Systems

A number of institutional investors have recently added to or reduced their stakes in KRMD. First Light Asset Management LLC lifted its holdings in KORU Medical Systems by 5.1% in the 2nd quarter. First Light Asset Management LLC now owns 4,681,626 shares of the company’s stock valued at $16,760,000 after purchasing an additional 226,700 shares in the last quarter. Topline Capital Management LLC lifted its holdings in KORU Medical Systems by 1.1% in the 3rd quarter. Topline Capital Management LLC now owns 3,648,240 shares of the company’s stock valued at $13,973,000 after purchasing an additional 39,893 shares in the last quarter. Vanguard Group Inc. lifted its holdings in KORU Medical Systems by 2.9% in the 3rd quarter. Vanguard Group Inc. now owns 2,145,772 shares of the company’s stock valued at $8,218,000 after purchasing an additional 60,109 shares in the last quarter. Geode Capital Management LLC lifted its holdings in KORU Medical Systems by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 1,022,860 shares of the company’s stock valued at $5,944,000 after purchasing an additional 16,062 shares in the last quarter. Finally, Acuitas Investments LLC lifted its holdings in KORU Medical Systems by 89.6% in the 3rd quarter. Acuitas Investments LLC now owns 763,088 shares of the company’s stock valued at $2,923,000 after purchasing an additional 360,594 shares in the last quarter. Institutional investors and hedge funds own 58.60% of the company’s stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.